Brittany O'Brien
Associate Professor of Psychiatry and Behavioral Sciences at Baylor College of Medicine
Data updated
Research Footprint
Brittany O'Brien appears in 5 tracked papers (2019–2024), most studied alongside Ketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
Most-cited paper: The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression (33 citations).
Frequent co-authors: Sanjay Mathew, Alan Craig Swann and Lauren Averill.
Background & Research
Brittany O'Brien, Ph.D., is a licensed clinical psychologist and Associate Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine. Her research focuses on novel interventions for mood and trauma-related disorders, especially ketamine and psilocybin, and she has coauthored several influential ketamine studies on depression, suicidality, and trauma history.
Key Impact
She is a notable clinical psychologist and ketamine/psilocybin researcher whose work has helped characterize antidepressant and anti-suicidal response trajectories to intravenous ketamine in treatment-resistant depression.
Collaboration Network
5 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Brittany O'Brien is associated with.